If I were to design a program like this, I would start with the most compelling evidence-based basket of medicines that should be provided.
You've heard witnesses testify that some of those compelling medicines, including GLP-1 drugs, such as Ozempic, are outside of the current proposed basket, so you might go back and think carefully about what would be included.
I want to be clear that if you do this as a truly universal plan, as a truly single-payer plan, buying medicines on behalf of 40 million Canadians, you would have such purchasing power that you could include a comprehensive basket of treatments for contraception and diabetes and save considerable funding while doing so. It can be done in a very prudent way, and it should be evidence-based but also sufficiently well funded so that it does meet the needs Canadians have.